Abstract:Toxicogenomics (TGx) can be considered as a maturing discipline that aims to delineate the complex molecular response to environmental stress and chemicals as well as to drug treatment. Different types of TGx studies have different goals: (1) mechanistic toxicology TGx aims at revealing the molecular basis of toxicity mechanisms; (2) comparative toxicology TGx compares gene expression change patterns among many chemicals to identify their sharing modes of action; and (3) predictive toxicology TGx develops and validates a predictive signature or biomarker for a specific toxicity. Regardless of study type, the TGx data are both prodigious and highly complex, making biologically sound conclusions drawn from proper interpretation strategies a difficult overtaking. This chapter covers a broad range of topics related to TGx study data interpretation. Strategies such as pathway and functional analysis, chromosome mapping, and integration with data from other omics platforms are discussed. Phenotypic anchoring, the process of causality associating the gene expression alteration with phenotypic outcome, is also discussed. Integrating genomics data with proteomics and/or metabolomics data, the so-called systems toxicology approach, is another powerful interpretive approach. Public and private databases enabling interpretive context and software to integrate and analyze data are also summarized. For all the different interpretation techniques provided throughout the chapter, examples of studies and available tools are also provided. Most importantly, the issues and challenges associated with these topics are emphasized so that the readers can gain an overall perspective of preferred approaches for using the existing technology. The ways and means of interpreting TGx data is evolving rapidly. The authors ardently expect that the snapshot of current methods outlined here will soon be refined, or replaced with new innovations, paving the way for a paradigm shift in the toxicological sciences.

Toxicogenomics: A 2020 Vision.

Interpretation of Toxicogenomics Data

Research progress in drug toxicology based on systems biology

Progress in toxicogenomics to protect human health

[Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Approaches and Practical Considerations for the Analysis of Toxicogenomics Data

In Pursuit of Effective Toxicogenomics

Narrowing the Gap Between in Vitro and in Vivo Genetic Profiles by Deconvoluting Toxicogenomic Data in Silico

Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver

The Perspectives of Toxicogenomics

A Study of Toxicogenomics and Its Current Applications in the Safety of Traditional Chinese Medicine

Genomic and Proteomic Approaches for Predicting Toxicity and Adverse Drug Reactions.

Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective

Bidirectional Translation of Transcriptomic Profiles between Liver and Kidney under Drug Treatment Using Generative Adversarial Networks (GANs)

Progress and promises in toxicogenomics in aquatic toxicology: Is technical innovation driving scientific innovation?

Application of genomics in preclinical drug safety evaluation.

Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs

Toxicogenomics and drug discovery: will new technologies help us produce better drugs?

Review of Current and “omics” Methods for Assessing the Toxicity (genotoxicity, Teratogenicity and Nephrotoxicity) of Herbal Medicines and Mushrooms